Skip to content

Evaluation of Tp-e Interval and Tp-e/QT Ratio in Dermatomyositis and Analysis of Their Relationship With Inflammation

The Third People's Hospital of Hangzhou

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT06002750
Enrollment
100
Registered
2023-08-21
Start date
2021-11-24
Completion date
2022-11-24
Last updated
2025-02-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Dermatomyositis, Inflammation, Myocardial Repolarization

Brief summary

The goal of this observational study is to investigate ventricular repolarization utilizing Tp-e intervals and Tp-e/QT ratios in patients with DM. The main questions it aims to answer are: * 1.Exploring the changes in ventricular repolarization parameters (QT interval, QTc interval, QTd, Tp-e interval, Tp-e/QT ratio) in patients with dermatomyositis, providing quantifiable indicators for early detection of arrhythmia in dermatomyositis patients; * 2.Exploring the role of inflammation in ventricular repolarization in DM patients, providing a basis for in-depth research on the diagnosis and prevention of arrhythmia in DM patients.

Interventions

OTHERdisease

Do you have dermatomyositis

Sponsors

The Third People's Hospital of Hangzhou
Lead SponsorOTHER

Study design

Observational model
OTHER
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
20 Years to 80 Years
Healthy volunteers
Yes

Inclusion criteria

Regardless of gender, registered residence and education level, voluntarily participate in this study and sign the informed consent form. Clinical diagnosis of Dermatomyositis.

Exclusion criteria

Previous history of heart disease (such as myocardial infarction, cardiac pacing, congenital heart disease, ischemic heart disease, etc.), chronic kidney disease, etc; Patients with other connective tissue diseases; Pregnant and lactating women. Taking drugs that affect electrocardiogram indicators, such as macrolides, quinolones, quinidine, amiodarone, antipsychotic drugs, etc. Patients with severe lack of case data.

Design outcomes

Primary

MeasureTime frame
QTc, Tp-e interval, and Tp-e/QT ratio were increased in DM patients.November 2011 to November 2022
the Tp-e interval and Tp-e/QT ratio were positively correlated with Inflammation.November 2011 to November 2022

Countries

China

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026